Table 2.

Age-, gender, and pubertal status- adjusted linear regression coefficients between RMM and clinical variables.

	All cases	NAFLD
	B coefficients (95% CI)	B coefficients (95% CI)
Waist circumference, cm	−0.320 (-0.387,−0.253)§	−0.327 (-0.414,−0.240)§
Systolic BP, mmHg	−0.081 (-0.167, 0.006)	−0.175 (-0.290,−0.060)*
Diastolic BP, mmHg	−0.101 (-0.199,−0.002)*	−0.107 (-0.261, 0.047)
ALT	−0.035 (-0.060,−0.009)+	−0.032 (-0.061,−0.002)*
HDL-C, mg/dL	0.057 (-0.13, 0.127)	0.173 (0.07, 0.278)+
Triglycerides, mg/dL	−0.014 (-0.25,−0.002)*	−0.015 (-0.029,−0.001)*
TG/HDL-C ratio	−0.454 (-0.78,−0.12)+	−0.500 (-0.87,−0.13)+
Glucose	−0.307 (-1.76, 1.15)	−0.903 (-2.54, 0.74)
Insulin	−0.136 (-0.204,−0.067)§	−0.125 (-0.197,−0.052)+
HOMA-IR	−0.396 (-0.632,−0.161)+	−0.346 (-0.585,−0.108)+

RMM, relative muscle mass; NAFLD, nonalcoholic fatty liver disease; CI, confidence interval; BP, blood pressure; ALT, alanine aminotransferase; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance.

^*P < 0.05;

⁺P < 0.01;

^§P < 0.0001.